OIL 1.96% 5.0¢ optiscan imaging limited

Additional to Carl Zeiss's Convivo, "OIL's" "Five2" for "non in...

  1. 806 Posts.
    lightbulb Created with Sketch. 17
    Additional to Carl Zeiss's Convivo,
    "OIL's" "Five2" for "non in vivo applications" can now already be actively sold and will also already provide revenues,

    until the "Five2Clinical" with it's sterilisation sheaths" has the approvals for the US and European market!
    I can imagine that (and hope) aproval times will be shorter then 6-12 months, as OIL can lean on the "Convivo" approval procedure with perhaps some support and advice from Carl Zeiss.

 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
5.0¢
Change
-0.001(1.96%)
Mkt cap ! $23.97M
Open High Low Value Volume
5.1¢ 5.1¢ 5.0¢ $13.21K 262.9K

Buyers (Bids)

No. Vol. Price($)
1 40000 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.1¢ 137040 2
View Market Depth
Last update - 15.30pm 19/07/2019 (20 minute delay) ?
(live)
Last
5.0¢
  Change
-0.001 ( 1.96 %)
Open High Low Volume
5.0¢ 5.0¢ 5.0¢ 60000
Last updated 15.30pm 19/07/2019 (live) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.